279 related articles for article (PubMed ID: 32863206)
1. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
[TBL] [Abstract][Full Text] [Related]
2. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
Chen X; Bai B; Tian Y; Du H; Chen J
J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
[TBL] [Abstract][Full Text] [Related]
4. Apelin binding to human APJ receptor leads to biased signaling.
Kumar P; Ashokan A; Aradhyam GK
Biochim Biophys Acta; 2016 Dec; 1864(12):1748-1756. PubMed ID: 27671350
[TBL] [Abstract][Full Text] [Related]
5. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants on extracellular loop domains that dictate interaction between β-arrestin and human APJ receptor.
Ashokan A; Kameswaran M; Aradhyam GK
FEBS Lett; 2019 Mar; 593(6):634-643. PubMed ID: 30801688
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Elabela and Apelin on Apelin Receptor Activation Through β-Arrestin Recruitment.
Zhang H; Chen J; Shi M; Xu F; Zhang X; Gong DW
Mol Biotechnol; 2023 Mar; 65(3):394-400. PubMed ID: 35960440
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
9. Heterodimerization of apelin and opioid receptor-like 1 receptors mediates apelin-13-induced G protein biased signaling.
Chen J; Wang Z; Zhang R; Yin H; Wang P; Wang C; Jiang Y
Life Sci; 2023 Sep; 328():121892. PubMed ID: 37364634
[TBL] [Abstract][Full Text] [Related]
10. Loss of APJ mediated β-arrestin signalling improves high-fat diet induced metabolic dysfunction but does not alter cardiac function in mice.
Li N; Ma X; Ban T; Xu S; Ma Y; Ason B; Hu LA
Biochem J; 2020 Sep; 477(17):3313-3327. PubMed ID: 32779693
[TBL] [Abstract][Full Text] [Related]
11. Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine.
Ceraudo E; Galanth C; Carpentier E; Banegas-Font I; Schonegge AM; Alvear-Perez R; Iturrioz X; Bouvier M; Llorens-Cortes C
J Biol Chem; 2014 Aug; 289(35):24599-610. PubMed ID: 25012663
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced internalization and desensitization of the apelin receptor.
Pope GR; Tilve S; McArdle CA; Lolait SJ; O'Carroll AM
Mol Cell Endocrinol; 2016 Dec; 437():108-119. PubMed ID: 27492965
[TBL] [Abstract][Full Text] [Related]
13. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
[TBL] [Abstract][Full Text] [Related]
14. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
15. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats.
Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165
[TBL] [Abstract][Full Text] [Related]
16. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of apelin and Elabela in cardiovascular disease.
Gao S; Chen H
Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
[TBL] [Abstract][Full Text] [Related]
18. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
20. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
